Abstract
Artificial oxygen carriers were originally developed as a substitute for red blood cells (RBC) for transfusion. As the blood demand-supply balance becomes critical, it is reasonable to explore artificial oxygen (O2) carriers.
Cite
CITATION STYLE
APA
Kawaguchi, A. T., Murayama, C., Yoshiba, F., Furuya, H., Yamano, M., & Haida, M. (2014). Liposome-encapsulated hemoglobin: Potential clinical applications. In Hemoglobin-Based Oxygen Carriers as Red Cell Substitutes and Oxygen Therapeutics (Vol. 9783642407178, pp. 369–383). Springer-Verlag Berlin Heidelberg. https://doi.org/10.1007/978-3-642-40717-8_21
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free